{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:47:13Z","timestamp":1783446433162,"version":"3.55.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1R21 MH123303 and 1R01 MH132517"],"award-info":[{"award-number":["1R21 MH123303 and 1R01 MH132517"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02197-4","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:44:34Z","timestamp":1765010674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glycogen synthase kinase-3 activation and dysregulation of amyloid transport receptors expression and shedding in HIV-induced Alzheimer\u2019s disease-like pathology: modulatory effects of CCR5 antagonists"],"prefix":"10.1186","volume":"14","author":[{"given":"Biju","family":"Bhargavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendran","family":"Annadurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgette D.","family":"Kanmogne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"2197_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11481-009-9152-8","volume":"4","author":"CL Achim","year":"2009","unstructured":"Achim CL, Adame A, Dumaop W, Everall IP, Masliah E (2009) Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol 4:190\u2013199. https:\/\/doi.org\/10.1007\/s11481-009-9152-8","journal-title":"J Neuroimmune Pharmacol"},{"key":"2197_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102058","volume":"24","author":"AC Amaral","year":"2021","unstructured":"Amaral AC, Perez-Nievas BG, Siao Tick Chong M, Gonzalez-Martinez A, Argente-Escrig H, Rubio-Guerra S, Commins C, Muftu S, Eftekharzadeh B, Hudry E et al (2021) Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3\u03b2) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation. iScience 24:102058. https:\/\/doi.org\/10.1016\/j.isci.2021.102058","journal-title":"iScience"},{"key":"2197_CR3","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/j.1471-4159.2004.02948.x","volume":"92","author":"W-L An","year":"2005","unstructured":"An W-L, Bjorkdahl C, Liu R, Cowburn RF, Winblad B, Pei J-J (2005) Mechanism of zinc-induced phosphorylation of p70\u2003S6 kinase and glycogen synthase kinase 3\u03b2 in SH-SY5Y neuroblastoma cells. J Neurochem 92:1104\u20131115. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02948.x","journal-title":"J Neurochem"},{"issue":"17","key":"2197_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171415","volume":"13","author":"N Annadurai","year":"2024","unstructured":"Annadurai N, Kanmogne GD (2024) Structural and functional dysregulation of the brain endothelium in HIV infection and substance abuse. Cells 13(17):1415. https:\/\/doi.org\/10.3390\/cells13171415","journal-title":"Cells"},{"key":"2197_CR5","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1038\/sj.emboj.7600415","volume":"23","author":"O Arancio","year":"2004","unstructured":"Arancio O, Zhang HP, Chen X, Lin C, Trinchese F, Puzzo D, Liu S, Hegde A, Yan SF, Stern A et al (2004) RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO J 23:4096\u20134105. https:\/\/doi.org\/10.1038\/sj.emboj.7600415","journal-title":"EMBO J"},{"key":"2197_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13024-021-00500-0","volume":"16","author":"B Bhargavan","year":"2021","unstructured":"Bhargavan B, Woollard SM, McMillan JE, Kanmogne GD (2021) CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice. Mol Neurodegener 16:78. https:\/\/doi.org\/10.1186\/s13024-021-00500-0","journal-title":"Mol Neurodegener"},{"key":"2197_CR7","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/B978-0-7020-4088-7.00090-0","volume":"121","author":"M Bilgrami","year":"2014","unstructured":"Bilgrami M, O\u2019Keefe P (2014) Neurologic diseases in HIV-infected patients. Handb Clin Neurol 121:1321\u20131344. https:\/\/doi.org\/10.1016\/B978-0-7020-4088-7.00090-0","journal-title":"Handb Clin Neurol"},{"issue":"Pt 3","key":"2197_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1042\/bj3230577","volume":"323","author":"ML Billingsley","year":"1997","unstructured":"Billingsley ML, Kincaid RL (1997) Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 323(Pt 3):577\u2013591. https:\/\/doi.org\/10.1042\/bj3230577","journal-title":"Biochem J"},{"key":"2197_CR9","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1016\/j.jmb.2018.06.027","volume":"430","author":"A Brelot","year":"2018","unstructured":"Brelot A, Chakrabarti LA (2018) CCR5 revisited: how mechanisms of HIV entry govern AIDS pathogenesis. J Mol Biol 430:2557\u20132589. https:\/\/doi.org\/10.1016\/j.jmb.2018.06.027","journal-title":"J Mol Biol"},{"key":"2197_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11481-008-9143-1","volume":"4","author":"BJ Brew","year":"2009","unstructured":"Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G (2009) Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol 4:163\u2013174. https:\/\/doi.org\/10.1007\/s11481-008-9143-1","journal-title":"J Neuroimmune Pharmacol"},{"key":"2197_CR11","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.19.1.20697","volume":"19","author":"W Cao","year":"2016","unstructured":"Cao W, Mehraj V, Kaufmann DE, Li T, Routy JP (2016) Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era. J Int AIDS Soc 19:20697. https:\/\/doi.org\/10.7448\/IAS.19.1.20697","journal-title":"J Int AIDS Soc"},{"key":"2197_CR12","doi-asserted-by":"publisher","first-page":"23331","DOI":"10.1074\/jbc.M113.463984","volume":"288","author":"A Cavallini","year":"2013","unstructured":"Cavallini A, Brewerton S, Bell A, Sargent S, Glover S, Hardy C, Moore R, Calley J, Ramachandran D, Poidinger M et al (2013) An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease. J Biol Chem 288:23331\u201323347. https:\/\/doi.org\/10.1074\/jbc.M113.463984","journal-title":"J Biol Chem"},{"key":"2197_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bbadis.2005.03.014","volume":"1741","author":"MO Chaney","year":"2005","unstructured":"Chaney MO, Stine WB, Kokjohn TA, Kuo YM, Esh C, Rahman A, Luehrs DC, Schmidt AM, Stern D, Yan SD et al (2005) RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling. Biochim Biophys Acta 1741:199\u2013205. https:\/\/doi.org\/10.1016\/j.bbadis.2005.03.014","journal-title":"Biochim Biophys Acta"},{"key":"2197_CR14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600567","volume":"28","author":"A Chaudhuri","year":"2008","unstructured":"Chaudhuri A, Duan F, Morsey B, Persidsky Y, Kanmogne GD (2008) HIV-1 activates proinflammatory and interferon-inducible genes in human brain microvascular endothelial cells: putative mechanisms of blood-brain barrier dysfunction. J Cereb Blood Flow Metab 28:697\u2013711. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600567","journal-title":"J Cereb Blood Flow Metab"},{"key":"2197_CR15","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1182\/blood-2007-05-091207","volume":"111","author":"A Chaudhuri","year":"2008","unstructured":"Chaudhuri A, Yang B, Gendelman HE, Persidsky Y, Kanmogne GD (2008) STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 111:2062\u20132072. https:\/\/doi.org\/10.1182\/blood-2007-05-091207","journal-title":"Blood"},{"key":"2197_CR16","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.micinf.2004.08.004","volume":"6","author":"T Chavakis","year":"2004","unstructured":"Chavakis T, Bierhaus A, Nawroth PP (2004) RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect 6:1219\u20131225. https:\/\/doi.org\/10.1016\/j.micinf.2004.08.004","journal-title":"Microbes Infect"},{"key":"2197_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/S1461145711000149","volume":"15","author":"CH Chen","year":"2012","unstructured":"Chen CH, Zhou W, Liu S, Deng Y, Cai F, Tone M, Tone Y, Tong Y, Song W (2012) Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer\u2019s disease. Int J Neuropsychopharmacol 15:77\u201390. https:\/\/doi.org\/10.1017\/S1461145711000149","journal-title":"Int J Neuropsychopharmacol"},{"key":"2197_CR18","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1096\/fj.08-126383","volume":"23","author":"HJ Cho","year":"2009","unstructured":"Cho HJ, Son SM, Jin SM, Hong HS, Shin DH, Kim SJ, Huh K, Mook-Jung I (2009) RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer\u2019s disease animal model. FASEB J 23:2639\u20132649. https:\/\/doi.org\/10.1096\/fj.08-126383","journal-title":"FASEB J"},{"key":"2197_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/187152709787601867","volume":"8","author":"R Deane","year":"2009","unstructured":"Deane R, Bell RD, Sagare A, Zlokovic BV (2009) Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 8:16\u201330. https:\/\/doi.org\/10.2174\/187152709787601867","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2197_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890","volume":"9","author":"R Deane","year":"2003","unstructured":"Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J et al (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9:907\u2013913. https:\/\/doi.org\/10.1038\/nm890","journal-title":"Nat Med"},{"key":"2197_CR21","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1161\/01.STR.0000143452.85382.d1","volume":"35","author":"R Deane","year":"2004","unstructured":"Deane R, Wu Z, Zlokovic BV (2004) RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke 35:2628\u20132631. https:\/\/doi.org\/10.1161\/01.STR.0000143452.85382.d1","journal-title":"Stroke"},{"key":"2197_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.35","volume":"1","author":"SG Deeks","year":"2015","unstructured":"Deeks SG, Overbaugh J, Phillips A, Buchbinder S (2015) HIV infection. Nat Rev Dis Primers 1:15035. https:\/\/doi.org\/10.1038\/nrdp.2015.35","journal-title":"Nat Rev Dis Primers"},{"key":"2197_CR23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/381661a0","volume":"381","author":"H Deng","year":"1996","unstructured":"Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM et al (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661\u2013666. https:\/\/doi.org\/10.1038\/381661a0","journal-title":"Nature"},{"key":"2197_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.nbd.2009.04.003","volume":"35","author":"I Dewachter","year":"2009","unstructured":"Dewachter I, Ris L, Jaworski T, Seymour CM, Kremer A, Borghgraef P, De Vijver H, Godaux E, Van Leuven F (2009) GSK3\u00df, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at Serine-9. Neurobiol Dis 35:193\u2013200. https:\/\/doi.org\/10.1016\/j.nbd.2009.04.003","journal-title":"Neurobiol Dis"},{"key":"2197_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","volume":"112","author":"JE Donahue","year":"2006","unstructured":"Donahue JE, Flaherty SL, Johanson CE, Duncan JA 3rd, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E et al (2006) RAGE, LRP-1, and amyloid-beta protein in Alzheimer\u2019s disease. Acta Neuropathol 112:405\u2013415. https:\/\/doi.org\/10.1007\/s00401-006-0115-3","journal-title":"Acta Neuropathol"},{"key":"2197_CR26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41582-023-00879-y","volume":"19","author":"RJ Ellis","year":"2023","unstructured":"Ellis RJ, Marquine MJ, Kaul M, Fields JA, Schlachetzki JCM (2023) Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management. Nat Rev Neurol 19:668\u2013687. https:\/\/doi.org\/10.1038\/s41582-023-00879-y","journal-title":"Nat Rev Neurol"},{"key":"2197_CR27","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1001\/archneur.62.11.1734","volume":"62","author":"E Emanuele","year":"2005","unstructured":"Emanuele E, D\u2019Angelo A, Tomaino C, Binetti G, Ghidoni R, Politi P, Bernardi L, Maletta R, Bruni AC, Geroldi D (2005) Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch Neurol 62:1734\u20131736. https:\/\/doi.org\/10.1001\/archneur.62.11.1734","journal-title":"Arch Neurol"},{"key":"2197_CR28","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1471-4159.2006.04139.x","volume":"99","author":"T Engel","year":"2006","unstructured":"Engel T, Goni-Oliver P, Lucas JJ, Avila J, Hernandez F (2006) Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. J Neurochem 99:1445\u20131455. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04139.x","journal-title":"J Neurochem"},{"key":"2197_CR29","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.neurobiolaging.2005.06.010","volume":"27","author":"T Engel","year":"2006","unstructured":"Engel T, Lucas JJ, Gomez-Ramos P, Moran MA, Avila J, Hernandez F (2006) Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration. Neurobiol Aging 27:1258\u20131268. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.06.010","journal-title":"Neurobiol Aging"},{"key":"2197_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101958","volume":"42","author":"JD Erusalimsky","year":"2021","unstructured":"Erusalimsky JD (2021) The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes. Redox Biol 42:101958. https:\/\/doi.org\/10.1016\/j.redox.2021.101958","journal-title":"Redox Biol"},{"key":"2197_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jnnp.65.1.29","volume":"65","author":"MM Esiri","year":"1998","unstructured":"Esiri MM, Biddolph SC, Morris CS (1998) Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 65:29\u201333. https:\/\/doi.org\/10.1136\/jnnp.65.1.29","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2197_CR32","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/hmg\/ddy017","volume":"27","author":"F Fang","year":"2018","unstructured":"Fang F, Yu Q, Arancio O, Chen D, Gore SS, Yan SS, Yan SF (2018) RAGE mediates Abeta accumulation in a mouse model of Alzheimer\u2019s disease via modulation of beta- and gamma-secretase activity. Hum Mol Genet 27:1002\u20131014. https:\/\/doi.org\/10.1093\/hmg\/ddy017","journal-title":"Hum Mol Genet"},{"key":"2197_CR33","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-002-0587-8","volume":"104","author":"I Ferrer","year":"2002","unstructured":"Ferrer I, Barrachina M, Puig B (2002) Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer\u2019s disease, Pick\u2019s disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol 104:583\u2013591. https:\/\/doi.org\/10.1007\/s00401-002-0587-8","journal-title":"Acta Neuropathol"},{"key":"2197_CR34","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/hmg\/dds533","volume":"22","author":"A Fuster-Matanzo","year":"2013","unstructured":"Fuster-Matanzo A, Llorens-Martin M, Sirerol-Piquer MS, Garcia-Verdugo JM, Avila J, Hernandez F (2013) Dual effects of increased glycogen synthase kinase-3beta activity on adult neurogenesis. Hum Mol Genet 22:1300\u20131315. https:\/\/doi.org\/10.1093\/hmg\/dds533","journal-title":"Hum Mol Genet"},{"key":"2197_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/1567205014666170417111859","volume":"15","author":"Y Gao","year":"2018","unstructured":"Gao Y, Tan L, Yu JT, Tan L (2018) Tau in Alzheimer\u2019s disease: mechanisms and therapeutic strategies. Curr Alzheimer Res 15:283\u2013300. https:\/\/doi.org\/10.2174\/1567205014666170417111859","journal-title":"Curr Alzheimer Res"},{"key":"2197_CR36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1074\/jbc.M117.786756","volume":"293","author":"J Gasparotto","year":"2018","unstructured":"Gasparotto J, Girardi CS, Somensi N, Ribeiro CT, Moreira JCF, Michels M, Sonai B, Rocha M, Steckert AV, Barichello T et al (2018) Receptor for advanced glycation end products mediates sepsis-triggered amyloid-beta accumulation, Tau phosphorylation, and cognitive impairment. J Biol Chem 293:226\u2013244. https:\/\/doi.org\/10.1074\/jbc.M117.786756","journal-title":"J Biol Chem"},{"key":"2197_CR37","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00702-008-0069-9","volume":"115","author":"R Ghidoni","year":"2008","unstructured":"Ghidoni R, Benussi L, Glionna M, Franzoni M, Geroldi D, Emanuele E, Binetti G (2008) Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment. J Neural Transm 115:1047\u20131050. https:\/\/doi.org\/10.1007\/s00702-008-0069-9","journal-title":"J Neural Transm"},{"key":"2197_CR38","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/iub.187","volume":"61","author":"KP Giese","year":"2009","unstructured":"Giese KP (2009) GSK-3: a key player in neurodegeneration and memory. IUBMB Life 61:516\u2013521. https:\/\/doi.org\/10.1002\/iub.187","journal-title":"IUBMB Life"},{"key":"2197_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ana.410420108","volume":"42","author":"B Giometto","year":"1997","unstructured":"Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, Miller R, Tavolato B, Beckett AA, Scaravilli F (1997) Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol 42:34\u201340. https:\/\/doi.org\/10.1002\/ana.410420108","journal-title":"Ann Neurol"},{"key":"2197_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","volume":"19","author":"DA Green","year":"2005","unstructured":"Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19:407\u2013411","journal-title":"AIDS"},{"key":"2197_CR41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/s1050-1738(98)00029-2","volume":"8","author":"PG Grimsley","year":"1998","unstructured":"Grimsley PG, Quinn KA, Owensby DA (1998) Soluble low-density lipoprotein receptor-related protein. Trends Cardiovasc Med 8:363\u2013368. https:\/\/doi.org\/10.1016\/s1050-1738(98)00029-2","journal-title":"Trends Cardiovasc Med"},{"key":"2197_CR42","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 75:2087\u20132096. https:\/\/doi.org\/10.1212\/WNL.0b013e318200d727","journal-title":"Neurology"},{"key":"2197_CR43","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1046\/j.1471-4159.2002.01269.x","volume":"83","author":"F Hernandez","year":"2002","unstructured":"Hernandez F, Borrell J, Guaza C, Avila J, Lucas JJ (2002) Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments. J Neurochem 83:1529\u20131533. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.01269.x","journal-title":"J Neurochem"},{"key":"2197_CR44","unstructured":"HIVinfo (2024) FDA-approved HIV medicines. https:\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/fda-approved-hiv-medicines"},{"key":"2197_CR45","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0092-8674(00)80801-6","volume":"97","author":"MA Hofmann","year":"1999","unstructured":"Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P et al (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides. Cell 97:889\u2013901. https:\/\/doi.org\/10.1016\/s0092-8674(00)80801-6","journal-title":"Cell"},{"key":"2197_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1460-9568.2006.05245.x","volume":"25","author":"C Hooper","year":"2007","unstructured":"Hooper C, Markevich V, Plattner F, Killick R, Schofield E, Engel T, Hernandez F, Anderton B, Rosenblum K, Bliss T et al (2007) Glycogen synthase kinase-3 inhibition is integral to long-term potentiation. Eur J Neurosci 25:81\u201386. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.05245.x","journal-title":"Eur J Neurosci"},{"key":"2197_CR47","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1096\/fj.07-9909com","volume":"22","author":"BI Hudson","year":"2008","unstructured":"Hudson BI, Carter AM, Harja E, Kalea AZ, Arriero M, Yang H, Grant PJ, Schmidt AM (2008) Identification, classification, and expression of RAGE gene splice variants. FASEB J 22:1572\u20131580. https:\/\/doi.org\/10.1096\/fj.07-9909com","journal-title":"FASEB J"},{"key":"2197_CR48","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1523\/JNEUROSCI.0889-12.2012","volume":"32","author":"DE Hurtado","year":"2012","unstructured":"Hurtado DE, Molina-Porcel L, Carroll JC, Macdonald C, Aboagye AK, Trojanowski JQ, Lee VM (2012) Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer\u2019s disease. J Neurosci 32:7392\u20137402. https:\/\/doi.org\/10.1523\/JNEUROSCI.0889-12.2012","journal-title":"J Neurosci"},{"key":"2197_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1600-0404.2008.01133.x","volume":"120","author":"J Ilzecka","year":"2009","unstructured":"Ilzecka J (2009) Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis. Acta Neurol Scand 120:119\u2013122. https:\/\/doi.org\/10.1111\/j.1600-0404.2008.01133.x","journal-title":"Acta Neurol Scand"},{"key":"2197_CR50","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.neures.2006.07.006","volume":"56","author":"S Ito","year":"2006","unstructured":"Ito S, Ohtsuki S, Terasaki T (2006) Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1\u201340) across the rat blood-brain barrier. Neurosci Res 56:246\u2013252. https:\/\/doi.org\/10.1016\/j.neures.2006.07.006","journal-title":"Neurosci Res"},{"key":"2197_CR51","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3233\/JAD-2009-1074","volume":"17","author":"LB Jaeger","year":"2009","unstructured":"Jaeger LB, Dohgu S, Hwang MC, Farr SA, Murphy MP, Fleegal-DeMotta MA, Lynch JL, Robinson SM, Niehoff ML, Johnson SN et al (2009) Testing the neurovascular hypothesis of Alzheimer\u2019s disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. J Alzheimers Dis 17:553\u2013570. https:\/\/doi.org\/10.3233\/JAD-2009-1074","journal-title":"J Alzheimers Dis"},{"key":"2197_CR52","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1172\/JCI11013","volume":"106","author":"DE Kang","year":"2000","unstructured":"Kang DE, Pietrzik CU, Baum L, Chevallier N, Merriam DE, Kounnas MZ, Wagner SL, Troncoso JC, Kawas CH, Katzman R et al (2000) Modulation of amyloid beta-protein clearance and Alzheimer\u2019s disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest 106:1159\u20131166. https:\/\/doi.org\/10.1172\/JCI11013","journal-title":"J Clin Invest"},{"key":"2197_CR53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/sj.jcbfm.9600330","volume":"27","author":"GD Kanmogne","year":"2007","unstructured":"Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y (2007) HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab 27:123\u2013134. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600330","journal-title":"J Cereb Blood Flow Metab"},{"key":"2197_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.virol.2011.03.025","volume":"415","author":"K Kehn-Hall","year":"2011","unstructured":"Kehn-Hall K, Guendel I, Carpio L, Skaltsounis L, Meijer L, Al-Harthi L, Steiner JP, Nath A, Kutsch O, Kashanchi F (2011) Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors. Virology 415:56\u201368. https:\/\/doi.org\/10.1016\/j.virol.2011.03.025","journal-title":"Virology"},{"key":"2197_CR55","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.brainres.2007.10.064","volume":"1188","author":"SH Koh","year":"2008","unstructured":"Koh SH, Noh MY, Kim SH (2008) Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3. Brain Res 1188:254\u2013262. https:\/\/doi.org\/10.1016\/j.brainres.2007.10.064","journal-title":"Brain Res"},{"key":"2197_CR56","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.1523\/JNEUROSCI.6102-11.2012","volume":"32","author":"SY Kook","year":"2012","unstructured":"Kook SY, Hong HS, Moon M, Ha CM, Chang S, Mook-Jung I (2012) Abeta(1\u201342)-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca(2)(+)-calcineurin signaling. J Neurosci 32:8845\u20138854. https:\/\/doi.org\/10.1523\/JNEUROSCI.6102-11.2012","journal-title":"J Neurosci"},{"key":"2197_CR57","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/01.ATV.0000251502.88818.4b","volume":"27","author":"H Koyama","year":"2007","unstructured":"Koyama H, Shoji T, Fukumoto S, Shinohara K, Shoji T, Emoto M, Mori K, Tahara H, Ishimura E, Kakiya R et al (2007) Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 27:147\u2013153. https:\/\/doi.org\/10.1161\/01.ATV.0000251502.88818.4b","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2197_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratico D (2020) Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Cell Res 1867:118664. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118664","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2197_CR59","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.296.7.815","volume":"296","author":"MM Lederman","year":"2006","unstructured":"Lederman MM, Penn-Nicholson A, Cho M, Mosier D (2006) Biology of CCR5 and its role in HIV infection and treatment. JAMA 296:815\u2013826. https:\/\/doi.org\/10.1001\/jama.296.7.815","journal-title":"JAMA"},{"key":"2197_CR60","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/189246","volume":"2011","author":"P Lei","year":"2011","unstructured":"Lei P, Ayton S, Bush AI, Adlard PA (2011) GSK-3 in neurodegenerative diseases. Int J Alzheimers Dis 2011:189246. https:\/\/doi.org\/10.4061\/2011\/189246","journal-title":"Int J Alzheimers Dis"},{"key":"2197_CR61","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s004010100435","volume":"103","author":"K Leroy","year":"2002","unstructured":"Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP (2002) The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer\u2019s disease. Acta Neuropathol 103:91\u201399. https:\/\/doi.org\/10.1007\/s004010100435","journal-title":"Acta Neuropathol"},{"key":"2197_CR62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2990.2006.00795.x","volume":"33","author":"K Leroy","year":"2007","unstructured":"Leroy K, Yilmaz Z, Brion JP (2007) Increased level of active GSK-3beta in Alzheimer\u2019s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 33:43\u201355. https:\/\/doi.org\/10.1111\/j.1365-2990.2006.00795.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2197_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00432-x","volume":"13","author":"E Liu","year":"2024","unstructured":"Liu E, Zhang Y, Wang JZ (2024) Updates in Alzheimer\u2019s disease: from basic research to diagnosis and therapies. Transl Neurodegener 13:45. https:\/\/doi.org\/10.1186\/s40035-024-00432-x","journal-title":"Transl Neurodegener"},{"key":"2197_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-4-17","volume":"4","author":"Q Liu","year":"2009","unstructured":"Liu Q, Zhang J, Tran H, Verbeek MM, Reiss K, Estus S, Bu G (2009) LRP1 shedding in human brain: roles of ADAM10 and ADAM17. Mol Neurodegener 4:17. https:\/\/doi.org\/10.1186\/1750-1326-4-17","journal-title":"Mol Neurodegener"},{"key":"2197_CR65","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/mp.2013.4","volume":"18","author":"M Llorens-Martin","year":"2013","unstructured":"Llorens-Martin M, Fuster-Matanzo A, Teixeira CM, Jurado-Arjona J, Ulloa F, Defelipe J, Rabano A, Hernandez F, Soriano E, Avila J (2013) GSK-3beta overexpression causes reversible alterations on postsynaptic densities and dendritic morphology of hippocampal granule neurons in vivo. Mol Psychiatry 18:451\u2013460. https:\/\/doi.org\/10.1038\/mp.2013.4","journal-title":"Mol Psychiatry"},{"key":"2197_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00046","volume":"7","author":"M Llorens-Martin","year":"2014","unstructured":"Llorens-Martin M, Jurado J, Hernandez F, Avila J (2014) GSK-3beta, a pivotal kinase in Alzheimer disease. Front Mol Neurosci 7:46. https:\/\/doi.org\/10.3389\/fnmol.2014.00046","journal-title":"Front Mol Neurosci"},{"key":"2197_CR67","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/cns.12445","volume":"21","author":"ZM Long","year":"2015","unstructured":"Long ZM, Zhao L, Jiang R, Wang KJ, Luo SF, Zheng M, Li XF, He GQ (2015) Valproic acid modifies synaptic structure and accelerates neurite outgrowth via the glycogen synthase kinase-3beta signaling pathway in an Alzheimer\u2019s disease model. CNS Neurosci Ther 21:887\u2013897. https:\/\/doi.org\/10.1111\/cns.12445","journal-title":"CNS Neurosci Ther"},{"key":"2197_CR68","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2217\/14796708.4.2.167","volume":"4","author":"LF Lue","year":"2009","unstructured":"Lue LF, Walker DG, Jacobson S, Sabbagh M (2009) Receptor for advanced glycation end products: its role in Alzheimer\u2019s disease and other neurological diseases. Future Neurol 4:167\u2013177. https:\/\/doi.org\/10.2217\/14796708.4.2.167","journal-title":"Future Neurol"},{"key":"2197_CR69","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1172\/JCI64516","volume":"123","author":"PT Ly","year":"2013","unstructured":"Ly PT, Wu Y, Zou H, Wang R, Zhou W, Kinoshita A, Zhang M, Yang Y, Cai F, Woodgett J et al (2013) Inhibition of GSK3beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Invest 123:224\u2013235. https:\/\/doi.org\/10.1172\/JCI64516","journal-title":"J Clin Invest"},{"key":"2197_CR70","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1172\/JCI2029","volume":"102","author":"JB Mackic","year":"1998","unstructured":"Mackic JB, Stins M, McComb JG, Calero M, Ghiso J, Kim KS, Yan SD, Stern D, Schmidt AM, Frangione B et al (1998) Human blood-brain barrier receptors for Alzheimer\u2019s amyloid-beta 1\u201340. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest 102:734\u2013743. https:\/\/doi.org\/10.1172\/JCI2029","journal-title":"J Clin Invest"},{"key":"2197_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mcn.2015.01.001","volume":"65","author":"RR Masvekar","year":"2015","unstructured":"Masvekar RR, El-Hage N, Hauser KF, Knapp PE (2015) GSK3beta-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity. Mol Cell Neurosci 65:11\u201320. https:\/\/doi.org\/10.1016\/j.mcn.2015.01.001","journal-title":"Mol Cell Neurosci"},{"key":"2197_CR72","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science 330:1774. https:\/\/doi.org\/10.1126\/science.1197623","journal-title":"Science"},{"key":"2197_CR73","doi-asserted-by":"publisher","first-page":"18736","DOI":"10.1074\/jbc.M201979200","volume":"277","author":"P May","year":"2002","unstructured":"May P, Reddy YK, Herz J (2002) Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J Biol Chem 277:18736\u201318743. https:\/\/doi.org\/10.1074\/jbc.M201979200","journal-title":"J Biol Chem"},{"key":"2197_CR74","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","volume":"1230","author":"MC Miller","year":"2008","unstructured":"Miller MC, Tavares R, Johanson CE, Hovanesian V, Donahue JE, Gonzalez L, Silverberg GD, Stopa EG (2008) Hippocampal RAGE immunoreactivity in early and advanced Alzheimer\u2019s disease. Brain Res 1230:273\u2013280. https:\/\/doi.org\/10.1016\/j.brainres.2008.06.124","journal-title":"Brain Res"},{"key":"2197_CR75","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1021\/cn300110c","volume":"3","author":"JA Morales-Garcia","year":"2012","unstructured":"Morales-Garcia JA, Luna-Medina R, Alonso-Gil S, Sanz-Sancristobal M, Palomo V, Gil C, Santos A, Martinez A, Perez-Castillo A (2012) Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo. ACS Chem Neurosci 3:963\u2013971. https:\/\/doi.org\/10.1021\/cn300110c","journal-title":"ACS Chem Neurosci"},{"key":"2197_CR76","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/nar\/18.12.3587","volume":"18","author":"JP Morgenstern","year":"1990","unstructured":"Morgenstern JP, Land H (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18:3587\u20133596. https:\/\/doi.org\/10.1093\/nar\/18.12.3587","journal-title":"Nucleic Acids Res"},{"key":"2197_CR77","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.molmed.2024.06.005","volume":"30","author":"CD Moschopoulos","year":"2024","unstructured":"Moschopoulos CD, Alford K, Antoniadou A, Vera JH (2024) Cognitive impairment in people living with HIV: mechanisms, controversies, and future perspectives. Trends Mol Med 30:1076\u20131089. https:\/\/doi.org\/10.1016\/j.molmed.2024.06.005","journal-title":"Trends Mol Med"},{"key":"2197_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00133","volume":"9","author":"D Munoz-Mayorga","year":"2018","unstructured":"Munoz-Mayorga D, Guerra-Araiza C, Torner L, Morales T (2018) Tau phosphorylation in female neurodegeneration: role of estrogens, progesterone, and prolactin. Front Endocrinol (Lausanne) 9:133. https:\/\/doi.org\/10.3389\/fendo.2018.00133","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2197_CR79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"A Nair","year":"2016","unstructured":"Nair A, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7:27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703","journal-title":"J Basic Clin Pharm"},{"key":"2197_CR80","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1161\/01.ATV.0000133191.71196.90","volume":"24","author":"Y Naka","year":"2004","unstructured":"Naka Y, Bucciarelli LG, Wendt T, Lee LK, Rong LL, Ramasamy R, Yan SF, Schmidt AM (2004) RAGE axis: animal models and novel insights into the vascular complications of diabetes. Arterioscler Thromb Vasc Biol 24:1342\u20131349. https:\/\/doi.org\/10.1161\/01.ATV.0000133191.71196.90","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2197_CR81","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00401-005-1087-4","volume":"110","author":"H Nakashima","year":"2005","unstructured":"Nakashima H, Ishihara T, Suguimoto P, Yokota O, Oshima E, Kugo A, Terada S, Hamamura T, Trojanowski JQ, Lee VM et al (2005) Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies. Acta Neuropathol 110:547\u2013556. https:\/\/doi.org\/10.1007\/s00401-005-1087-4","journal-title":"Acta Neuropathol"},{"key":"2197_CR82","doi-asserted-by":"publisher","unstructured":"Nguyen TB, Lucero GR, Chana G, Hult BJ, Tatro ET, Masliah E, Grant I, Achim CL, Everall IP, Group HIVNR (2009) Glycogen synthase kinase-3beta (GSK-3beta) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus-mediated neurotoxicity in primary human neurons. J Neurovirol 15: 434-438 https:\/\/doi.org\/10.1080\/13550280903168131","DOI":"10.1080\/13550280903168131"},{"key":"2197_CR83","doi-asserted-by":"publisher","first-page":"e20202207","DOI":"10.1084\/jem.20202207","volume":"218","author":"AM Nikolakopoulou","year":"2021","unstructured":"Nikolakopoulou AM, Wang Y, Ma Q, Sagare AP, Montagne A, Huuskonen MT, Rege SV, Kisler K, Dai Z, Korbelin J et al (2021) Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A. J Exp Med 218:e20202207. https:\/\/doi.org\/10.1084\/jem.20202207","journal-title":"J Exp Med"},{"key":"2197_CR84","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/JAD-2009-1045","volume":"17","author":"N Origlia","year":"2009","unstructured":"Origlia N, Capsoni S, Cattaneo A, Fang F, Arancio O, Yan SD, Domenici L (2009) Abeta-dependent inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE. J Alzheimers Dis 17:59\u201368. https:\/\/doi.org\/10.3233\/JAD-2009-1045","journal-title":"J Alzheimers Dis"},{"key":"2197_CR85","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bbi.2018.03.007","volume":"70","author":"Y Pan","year":"2018","unstructured":"Pan Y, Short JL, Newman SA, Choy KHC, Tiwari D, Yap C, Senyschyn D, Banks WA, Nicolazzo JA (2018) Cognitive benefits of lithium chloride in APP\/PS1 mice are associated with enhanced brain clearance of beta-amyloid. Brain Behav Immun 70:36\u201347. https:\/\/doi.org\/10.1016\/j.bbi.2018.03.007","journal-title":"Brain Behav Immun"},{"key":"2197_CR86","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.febslet.2005.11.059","volume":"580","author":"JJ Pei","year":"2006","unstructured":"Pei JJ, An WL, Zhou XW, Nishimura T, Norberg J, Benedikz E, Gotz J, Winblad B (2006) P70 S6 kinase mediates tau phosphorylation and synthesis. FEBS Lett 580:107\u2013114. https:\/\/doi.org\/10.1016\/j.febslet.2005.11.059","journal-title":"FEBS Lett"},{"key":"2197_CR87","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2007.01.029","volume":"53","author":"S Peineau","year":"2007","unstructured":"Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E, Bouschet T et al (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53:703\u2013717. https:\/\/doi.org\/10.1016\/j.neuron.2007.01.029","journal-title":"Neuron"},{"key":"2197_CR88","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuropharm.2016.12.019","volume":"116","author":"P Perez-Domper","year":"2017","unstructured":"Perez-Domper P, Palomo V, Gradari S, Gil C, de Ceballos ML, Martinez A, Trejo JL (2017) The GSK-3-inhibitor VP2.51 produces antidepressant effects associated with adult hippocampal neurogenesis. Neuropharmacology 116:174\u2013187. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.12.019","journal-title":"Neuropharmacology"},{"key":"2197_CR89","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pnpbp.2013.12.001","volume":"50","author":"J Platenik","year":"2014","unstructured":"Platenik J, Fisar Z, Buchal R, Jirak R, Kitzlerova E, Zverova M, Raboch J (2014) GSK3beta, CREB, and BDNF in peripheral blood of patients with Alzheimer\u2019s disease and depression. Prog Neuropsychopharmacol Biol Psychiatry 50:83\u201393. https:\/\/doi.org\/10.1016\/j.pnpbp.2013.12.001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2197_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00136","volume":"7","author":"A Ramanathan","year":"2015","unstructured":"Ramanathan A, Nelson AR, Sagare AP, Zlokovic BV (2015) Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer\u2019s disease: the role, regulation and restoration of LRP1. Front Aging Neurosci 7:136. https:\/\/doi.org\/10.3389\/fnagi.2015.00136","journal-title":"Front Aging Neurosci"},{"key":"2197_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-11-13","volume":"11","author":"VR Rao","year":"2014","unstructured":"Rao VR, Ruiz AP, Prasad VR (2014) Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res Ther 11:13. https:\/\/doi.org\/10.1186\/1742-6405-11-13","journal-title":"AIDS Res Ther"},{"key":"2197_CR92","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1096\/fj.08-109033","volume":"22","author":"A Raucci","year":"2008","unstructured":"Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, Reiss K, Saftig P, Bianchi ME (2008) A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 22:3716\u20133727. https:\/\/doi.org\/10.1096\/fj.08-109033","journal-title":"FASEB J"},{"key":"2197_CR93","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH (2022) Phosphorylated Tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 23:12841. https:\/\/doi.org\/10.3390\/ijms232112841","journal-title":"Int J Mol Sci"},{"key":"2197_CR94","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ana.410370212","volume":"37","author":"GW Rebeck","year":"1995","unstructured":"Rebeck GW, Harr SD, Strickland DK, Hyman BT (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor\/low-density-lipoprotein receptor-related protein. Ann Neurol 37:211\u2013217. https:\/\/doi.org\/10.1002\/ana.410370212","journal-title":"Ann Neurol"},{"key":"2197_CR95","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ana.24270","volume":"76","author":"KF Roberts","year":"2014","unstructured":"Roberts KF, Elbert DL, Kasten TP, Patterson BW, Sigurdson WC, Connors RE, Ovod V, Munsell LY, Mawuenyega KG, Miller-Thomas MM et al (2014) Amyloid-beta efflux from the central nervous system into the plasma. Ann Neurol 76:837\u2013844. https:\/\/doi.org\/10.1002\/ana.24270","journal-title":"Ann Neurol"},{"key":"2197_CR96","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1523\/JNEUROSCI.4321-06.2007","volume":"27","author":"E Rockenstein","year":"2007","unstructured":"Rockenstein E, Torrance M, Adame A, Mante M, Bar-on P, Rose JB, Crews L, Masliah E (2007) Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer\u2019s disease are associated with reduced amyloid precursor protein phosphorylation. J Neurosci 27:1981\u20131991. https:\/\/doi.org\/10.1523\/JNEUROSCI.4321-06.2007","journal-title":"J Neurosci"},{"key":"2197_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.561470","volume":"13","author":"A Rodriguez-Matellan","year":"2020","unstructured":"Rodriguez-Matellan A, Avila J, Hernandez F (2020) Overexpression of GSK-3beta in adult Tet-OFF GSK-3beta transgenic mice, and not during embryonic or postnatal development, induces tau phosphorylation, neurodegeneration and learning deficits. Front Mol Neurosci 13:561470. https:\/\/doi.org\/10.3389\/fnmol.2020.561470","journal-title":"Front Mol Neurosci"},{"key":"2197_CR98","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuroscience.2020.05.024","volume":"440","author":"H Rosas-Hernandez","year":"2020","unstructured":"Rosas-Hernandez H, Cuevas E, Raymick JB, Robinson BL, Sarkar S (2020) Impaired amyloid beta clearance and brain microvascular dysfunction are present in the Tg-SwDI mouse model of Alzheimer\u2019s disease. Neuroscience 440:48\u201355. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.05.024","journal-title":"Neuroscience"},{"key":"2197_CR99","first-page":"1341","volume":"151","author":"JB Rottman","year":"1997","unstructured":"Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ (1997) Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am J Pathol 151:1341\u20131351","journal-title":"Am J Pathol"},{"key":"2197_CR100","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/nm1635","volume":"13","author":"A Sagare","year":"2007","unstructured":"Sagare A, Deane R, Bell RD, Johnson B, Hamm K, Pendu R, Marky A, Lenting PJ, Wu Z, Zarcone T et al (2007) Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med 13:1029\u20131031. https:\/\/doi.org\/10.1038\/nm1635","journal-title":"Nat Med"},{"key":"2197_CR101","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JAD-2010-101248","volume":"24","author":"AP Sagare","year":"2011","unstructured":"Sagare AP, Deane R, Zetterberg H, Wallin A, Blennow K, Zlokovic BV (2011) Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-beta is an early biomarker for mild cognitive impairment preceding Alzheimer\u2019s disease. J Alzheimers Dis 24:25\u201334. https:\/\/doi.org\/10.3233\/JAD-2010-101248","journal-title":"J Alzheimers Dis"},{"key":"2197_CR102","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2012.07.008","volume":"136","author":"AP Sagare","year":"2012","unstructured":"Sagare AP, Deane R, Zlokovic BV (2012) Low-density lipoprotein receptor-related protein 1: a physiological Abeta homeostatic mechanism with multiple therapeutic opportunities. Pharmacol Ther 136:94\u2013105. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.008","journal-title":"Pharmacol Ther"},{"key":"2197_CR103","doi-asserted-by":"publisher","unstructured":"Sayas CL, Avila J (2021) GSK-3 and Tau: A Key Duet in Alzheimer's Disease. Cells 10: https:\/\/doi.org\/10.3390\/cells10040721","DOI":"10.3390\/cells10040721"},{"key":"2197_CR104","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC (2016) HIV-associated neurocognitive disorder\u2013pathogenesis and prospects for treatment. Nat Rev Neurol 12:234\u2013248. https:\/\/doi.org\/10.1038\/nrneurol.2016.27","journal-title":"Nat Rev Neurol"},{"key":"2197_CR105","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1006\/abbi.1998.0813","volume":"357","author":"A Sengupta","year":"1998","unstructured":"Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, Iqbal K (1998) Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch Biochem Biophys 357:299\u2013309. https:\/\/doi.org\/10.1006\/abbi.1998.0813","journal-title":"Arch Biochem Biophys"},{"key":"2197_CR106","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","volume":"35","author":"L Sereno","year":"2009","unstructured":"Sereno L, Coma M, Rodriguez M, Sanchez-Ferrer P, Sanchez MB, Gich I, Agullo JM, Perez M, Avila J, Guardia-Laguarta C et al (2009) A novel GSK-3beta inhibitor reduces Alzheimer\u2019s pathology and rescues neuronal loss in vivo. Neurobiol Dis 35:359\u2013367. https:\/\/doi.org\/10.1016\/j.nbd.2009.05.025","journal-title":"Neurobiol Dis"},{"key":"2197_CR107","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1586\/14789450.5.2.207","volume":"5","author":"N Sergeant","year":"2008","unstructured":"Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, Bombois S, Blum D, Delacourte A, Pasquier F, Vanmechelen E et al (2008) Biochemistry of tau in Alzheimer\u2019s disease and related neurological disorders. Expert Rev Proteomics 5:207\u2013224. https:\/\/doi.org\/10.1586\/14789450.5.2.207","journal-title":"Expert Rev Proteomics"},{"key":"2197_CR108","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J et al (2000) Clearance of Alzheimer\u2019s amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489\u20131499. https:\/\/doi.org\/10.1172\/JCI10498","journal-title":"J Clin Invest"},{"key":"2197_CR109","first-page":"1","volume":"31","author":"J-W Shin","year":"2010","unstructured":"Shin J-W, Seol I-C, Son C-G (2010) Interpretation of animal dose and human equivalent dose for drug development. J Korean Orient Med 31:1\u20137","journal-title":"J Korean Orient Med"},{"key":"2197_CR110","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1194\/jlr.R075796","volume":"58","author":"M Shinohara","year":"2017","unstructured":"Shinohara M, Tachibana M, Kanekiyo T, Bu G (2017) Role of LRP1 in the pathogenesis of Alzheimer\u2019s disease: evidence from clinical and preclinical studies. J Lipid Res 58:1267\u20131281. https:\/\/doi.org\/10.1194\/jlr.R075796","journal-title":"J Lipid Res"},{"key":"2197_CR111","doi-asserted-by":"publisher","first-page":"688","DOI":"10.34172\/apb.2023.071","volume":"13","author":"SR Shri","year":"2023","unstructured":"Shri SR, Manandhar S, Nayak Y, Pai KSR (2023) Role of GSK-3beta inhibitors: new promises and opportunities for Alzheimer\u2019s disease. Adv Pharm Bull 13:688\u2013700. https:\/\/doi.org\/10.34172\/apb.2023.071","journal-title":"Adv Pharm Bull"},{"key":"2197_CR112","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/hipo.20805","volume":"21","author":"M Sirerol-Piquer","year":"2011","unstructured":"Sirerol-Piquer M, Gomez-Ramos P, Hernandez F, Perez M, Moran MA, Fuster-Matanzo A, Lucas JJ, Avila J, Garcia-Verdugo JM (2011) GSK3beta overexpression induces neuronal death and a depletion of the neurogenic niches in the dentate gyrus. Hippocampus 21:910\u2013922. https:\/\/doi.org\/10.1002\/hipo.20805","journal-title":"Hippocampus"},{"key":"2197_CR113","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s13365-019-00761-y","volume":"25","author":"V Soontornniyomkij","year":"2019","unstructured":"Soontornniyomkij V, Moore DJ, Gouaux B, Soontornniyomkij B, Sinsheimer JS, Levine AJ (2019) Associations of regional amyloid-beta plaque and phospho-tau pathology with biological factors and neuropsychological functioning among HIV-infected adults. J Neurovirol 25:741\u2013753. https:\/\/doi.org\/10.1007\/s13365-019-00761-y","journal-title":"J Neurovirol"},{"key":"2197_CR114","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0304-3940(95)11902-9","volume":"197","author":"BR Sperber","year":"1995","unstructured":"Sperber BR, Leight S, Goedert M, Lee VM (1995) Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Neurosci Lett 197:149\u2013153. https:\/\/doi.org\/10.1016\/0304-3940(95)11902-9","journal-title":"Neurosci Lett"},{"key":"2197_CR115","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/s0306-4522(02)00236-1","volume":"113","author":"K Spittaels","year":"2002","unstructured":"Spittaels K, Van den Haute C, Van Dorpe J, Terwel D, Vandezande K, Lasrado R, Bruynseels K, Irizarry M, Verhoye M, Van Lint J et al (2002) Neonatal neuronal overexpression of glycogen synthase kinase-3 beta reduces brain size in transgenic mice. Neuroscience 113:797\u2013808. https:\/\/doi.org\/10.1016\/s0306-4522(02)00236-1","journal-title":"Neuroscience"},{"key":"2197_CR116","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.neurobiolaging.2009.04.016","volume":"32","author":"V Srikanth","year":"2011","unstructured":"Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, Munch G (2011) Advanced glycation endproducts and their receptor RAGE in Alzheimer\u2019s disease. Neurobiol Aging 32:763\u2013777. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.04.016","journal-title":"Neurobiol Aging"},{"key":"2197_CR117","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1172\/JCI81108","volume":"126","author":"SE Storck","year":"2016","unstructured":"Storck SE, Meister S, Nahrath J, Meissner JN, Schubert N, Di Spiezio A, Baches S, Vandenbroucke RE, Bouter Y, Prikulis I et al (2016) Endothelial LRP1 transports amyloid-beta(1\u201342) across the blood-brain barrier. J Clin Invest 126:123\u2013136. https:\/\/doi.org\/10.1172\/JCI81108","journal-title":"J Clin Invest"},{"key":"2197_CR118","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1007\/s11095-017-2267-3","volume":"34","author":"SE Storck","year":"2017","unstructured":"Storck SE, Pietrzik CU (2017) Endothelial LRP1 - a potential target for the treatment of Alzheimer\u2019s disease\u202f: theme: drug discovery, development and delivery in Alzheimer\u2019s disease guest editor: Davide Brambilla. Pharm Res 34:2637\u20132651. https:\/\/doi.org\/10.1007\/s11095-017-2267-3","journal-title":"Pharm Res"},{"key":"2197_CR119","doi-asserted-by":"publisher","first-page":"20021","DOI":"10.1073\/pnas.0905686106","volume":"106","author":"K Takuma","year":"2009","unstructured":"Takuma K, Fang F, Zhang W, Yan S, Fukuzaki E, Du H, Sosunov A, McKhann G, Funatsu Y, Nakamichi N et al (2009) RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc Natl Acad Sci U S A 106:20021\u201320026. https:\/\/doi.org\/10.1073\/pnas.0905686106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2197_CR120","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brainresbull.2022.10.006","volume":"190","author":"DR Thal","year":"2022","unstructured":"Thal DR, Tome SO (2022) The central role of tau in Alzheimer\u2019s disease: from neurofibrillary tangle maturation to the induction of cell death. Brain Res Bull 190:204\u2013217. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.10.006","journal-title":"Brain Res Bull"},{"key":"2197_CR121","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.3390\/ijms25094697","volume":"25","author":"LJ Thompson","year":"2024","unstructured":"Thompson LJ, Genovese J, Hong Z, Singh MV, Singh VB (2024) HIV-associated neurocognitive disorder: A look into cellular and molecular pathology. Int J Mol Sci 25:4697. https:\/\/doi.org\/10.3390\/ijms25094697","journal-title":"Int J Mol Sci"},{"key":"2197_CR122","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","volume":"19","author":"JA Trejo-Lopez","year":"2022","unstructured":"Trejo-Lopez JA, Yachnis AT, Prokop S (2022) Neuropathology of Alzheimer\u2019s disease. Neurotherapeutics 19:173\u2013185. https:\/\/doi.org\/10.1007\/s13311-021-01146-y","journal-title":"Neurotherapeutics"},{"key":"2197_CR123","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fnagi.2019.00256","volume":"11","author":"NI Trushina","year":"2019","unstructured":"Trushina NI, Bakota L, Mulkidjanian AY, Brandt R (2019) The evolution of tau phosphorylation and interactions. Front Aging Neurosci 11:256. https:\/\/doi.org\/10.3389\/fnagi.2019.00256","journal-title":"Front Aging Neurosci"},{"key":"2197_CR124","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuropharm.2017.12.026","volume":"131","author":"H Wang","year":"2018","unstructured":"Wang H, Chen F, Du YF, Long Y, Reed MN, Hu M, Suppiramaniam V, Hong H, Tang SS (2018) Targeted inhibition of RAGE reduces amyloid-beta influx across the blood-brain barrier and improves cognitive deficits in db\/db mice. Neuropharmacology 131:143\u2013153. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.12.026","journal-title":"Neuropharmacology"},{"key":"2197_CR125","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.2147\/DDDT.S90580","volume":"9","author":"SM Woollard","year":"2015","unstructured":"Woollard SM, Kanmogne GD (2015) Maraviroc: a review of its use in HIV infection and beyond. Drug Des Devel Ther 9:5447\u20135468. https:\/\/doi.org\/10.2147\/DDDT.S90580","journal-title":"Drug Des Devel Ther"},{"key":"2197_CR126","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1742-4690-11-20","volume":"11","author":"SM Woollard","year":"2014","unstructured":"Woollard SM, Li H, Singh S, Yu F, Kanmogne GD (2014) HIV-1 induces cytoskeletal alterations and Rac1 activation during monocyte-blood-brain barrier interactions: modulatory role of CCR5. Retrovirology 11:20. https:\/\/doi.org\/10.1186\/1742-4690-11-20","journal-title":"Retrovirology"},{"key":"2197_CR127","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s12640-018-9895-1","volume":"34","author":"SH Xin","year":"2018","unstructured":"Xin SH, Tan L, Cao X, Yu JT, Tan L (2018) Clearance of amyloid beta and tau in Alzheimer\u2019s disease: from mechanisms to therapy. Neurotox Res 34:733\u2013748. https:\/\/doi.org\/10.1007\/s12640-018-9895-1","journal-title":"Neurotox Res"},{"key":"2197_CR128","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/ijms18091965","volume":"18","author":"Y Yamazaki","year":"2017","unstructured":"Yamazaki Y, Kanekiyo T (2017) Blood-brain barrier dysfunction and the pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci 18:1965. https:\/\/doi.org\/10.3390\/ijms18091965","journal-title":"Int J Mol Sci"},{"key":"2197_CR129","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbi.2019.05.033","volume":"85","author":"L Yan","year":"2020","unstructured":"Yan L, Xie Y, Satyanarayanan SK, Zeng H, Liu Q, Huang M, Ma Y, Wan JB, Yao X, Su KP et al (2020) Omega-3 polyunsaturated fatty acids promote brain-to-blood clearance of beta-Amyloid in a mouse model with Alzheimer\u2019s disease. Brain Behav Immun 85:35\u201345. https:\/\/doi.org\/10.1016\/j.bbi.2019.05.033","journal-title":"Brain Behav Immun"},{"key":"2197_CR130","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"SD Yan","year":"1996","unstructured":"Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J et al (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease. Nature 382:685\u2013691. https:\/\/doi.org\/10.1038\/382685a0","journal-title":"Nature"},{"key":"2197_CR131","first-page":"167","volume":"12","author":"SD Yan","year":"1998","unstructured":"Yan SD, Stern D, Kane MD, Kuo YM, Lampert HC, Roher AE (1998) RAGE-Abeta interactions in the pathophysiology of Alzheimer\u2019s disease. Restor Neurol Neurosci 12:167\u2013173","journal-title":"Restor Neurol Neurosci"},{"key":"2197_CR132","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11904-014-0255-3","volume":"12","author":"Z Zayyad","year":"2015","unstructured":"Zayyad Z, Spudich S (2015) Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV AIDS Rep 12:16\u201324. https:\/\/doi.org\/10.1007\/s11904-014-0255-3","journal-title":"Curr HIV AIDS Rep"},{"key":"2197_CR133","doi-asserted-by":"publisher","first-page":"35507","DOI":"10.1074\/jbc.M806948200","volume":"283","author":"L Zhang","year":"2008","unstructured":"Zhang L, Bukulin M, Kojro E, Roth A, Metz VV, Fahrenholz F, Nawroth PP, Bierhaus A, Postina R (2008) Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J Biol Chem 283:35507\u201335516. https:\/\/doi.org\/10.1074\/jbc.M806948200","journal-title":"J Biol Chem"},{"key":"2197_CR134","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1007\/s00018-009-0121-4","volume":"66","author":"L Zhang","year":"2009","unstructured":"Zhang L, Postina R, Wang Y (2009) Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer\u2019s disease. Cell Mol Life Sci 66:3923\u20133935. https:\/\/doi.org\/10.1007\/s00018-009-0121-4","journal-title":"Cell Mol Life Sci"},{"key":"2197_CR135","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14818","volume":"30","author":"J Zhao","year":"2024","unstructured":"Zhao J, Wei M, Guo M, Wang M, Niu H, Xu T, Zhou Y (2024) GSK3: a potential target and pending issues for treatment of Alzheimer\u2019s disease. CNS Neurosci Ther 30:e14818. https:\/\/doi.org\/10.1111\/cns.14818","journal-title":"CNS Neurosci Ther"},{"key":"2197_CR136","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1515\/revneuro-2015-0069","volume":"27","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Li D, Zhao J, Song J, Zhao Y (2016) The role of the low-density lipoprotein receptor-related protein 1 (LRP-1) in regulating blood-brain barrier integrity. Rev Neurosci 27:623\u2013634. https:\/\/doi.org\/10.1515\/revneuro-2015-0069","journal-title":"Rev Neurosci"},{"key":"2197_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103970","volume":"78","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Li S, Li M, Ke D, Wang Q, Yang Y, Liu GP, Wang XC, Liu E, Wang JZ (2022) Human tau accumulation promotes glycogen synthase kinase-3beta acetylation and thus upregulates the kinase: a vicious cycle in Alzheimer neurodegeneration. EBioMedicine 78:103970. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103970","journal-title":"EBioMedicine"},{"key":"2197_CR138","doi-asserted-by":"publisher","first-page":"12211","DOI":"10.1523\/JNEUROSCI.3321-07.2007","volume":"27","author":"LQ Zhu","year":"2007","unstructured":"Zhu LQ, Wang SH, Liu D, Yin YY, Tian Q, Wang XC, Wang Q, Chen JG, Wang JZ (2007) Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments. J Neurosci 27:12211\u201312220. https:\/\/doi.org\/10.1523\/JNEUROSCI.3321-07.2007","journal-title":"J Neurosci"},{"key":"2197_CR139","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","volume":"28","author":"BV Zlokovic","year":"2005","unstructured":"Zlokovic BV (2005) Neurovascular mechanisms of Alzheimer\u2019s neurodegeneration. Trends Neurosci 28:202\u2013208. https:\/\/doi.org\/10.1016\/j.tins.2005.02.001","journal-title":"Trends Neurosci"},{"key":"2197_CR140","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/jnc.14668","volume":"149","author":"S Zou","year":"2019","unstructured":"Zou S, Balinang JM, Paris JJ, Hauser KF, Fuss B, Knapp PE (2019) Effects of HIV-1 Tat on oligodendrocyte viability are mediated by CaMKIIbeta-GSK3beta interactions. J Neurochem 149:98\u2013110. https:\/\/doi.org\/10.1111\/jnc.14668","journal-title":"J Neurochem"},{"key":"2197_CR141","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s00018-017-2463-7","volume":"74","author":"L Zuroff","year":"2017","unstructured":"Zuroff L, Daley D, Black KL, Koronyo-Hamaoui M (2017) Clearance of cerebral Abeta in Alzheimer\u2019s disease: reassessing the role of microglia and monocytes. Cell Mol Life Sci 74:2167\u20132201. https:\/\/doi.org\/10.1007\/s00018-017-2463-7","journal-title":"Cell Mol Life Sci"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02197-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02197-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02197-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:11:14Z","timestamp":1768342274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-025-02197-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":141,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2197"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02197-4","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed under a protocol approved by the UNMC Institutional Animal Care and Use Committee (IACUC Protocol number 19\u2013141-01-FC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}